These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 2338765)
41. [Hypertrophic cardiomyopathy showing no 123I-BMIPP myocardial accumulation with type I CD36 deficiency]. Watanabe K; Miyajima S; Kusano Y; Tanabe N; Hirokawa Y Kaku Igaku; 1997 Jul; 34(7):481-6. PubMed ID: 9293711 [TBL] [Abstract][Full Text] [Related]
42. Abnormalities of cardiac sympathetic neuronal and left ventricular function in chronic mitral regurgitation: assessment by iodine-123 metaiodobenzylguanidine scintigraphy. Tsutsui H; Ando S; Kubota T; Kuroiwa-Matsumoto M; Egashira K; Sasaki M; Kuwabara Y; Koyanagi S; Yasui H; Takeshita A Am J Card Imaging; 1996 Jan; 10(1):14-22. PubMed ID: 8680129 [TBL] [Abstract][Full Text] [Related]
43. [Myocardial adrenergic nerve activity in valvular diseases assessed by iodine-123-metaiodobenzylguanidine myocardial scintigraphy]. Imamura Y; Fukuyama T J Cardiol; 1997; 29 Suppl 2():21-6. PubMed ID: 9211099 [TBL] [Abstract][Full Text] [Related]
44. [Serial change of 123I-metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy]. Yamakado K; Takeda K; Kitano T; Nakagawa T; Futagami Y; Konishi T; Hamada M; Nakano T; Ichihara T Kaku Igaku; 1990 Jul; 27(7):703-8. PubMed ID: 2232338 [TBL] [Abstract][Full Text] [Related]
45. [Evaluation of myocardial distribution of iodine-123 labeled metaiodobenzylguanidine (123I-MIBG) in normal subjects]. Tsuchimochi S; Tamaki N; Shirakawa S; Fujita T; Yonekura Y; Konishi J; Nohara R; Sasayama S; Nishioka K Kaku Igaku; 1994 Mar; 31(3):257-64. PubMed ID: 8176864 [TBL] [Abstract][Full Text] [Related]
46. Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy. Kuwahara T; Hamada M; Hiwada K J Nucl Med; 1998 Sep; 39(9):1486-91. PubMed ID: 9744329 [TBL] [Abstract][Full Text] [Related]
47. [Evaluation of myocardial sympathetic nerve function in patients with mitral valve prolapse using iodine-123-metaiodobenzylguanidine myocardial scintigraphy]. Kishi F; Nomura M; Yukinaka M; Saito K; Tabata T; Iuchi A; Fukuda N; Oki T; Ito S; Nakaya Y J Cardiol; 1996; 27 Suppl 2():21-8; discussion 29-30. PubMed ID: 9067814 [TBL] [Abstract][Full Text] [Related]
48. Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM. Turpeinen AK; Vanninen E; Kuikka JT; Uusitupa MI Diabetes Care; 1996 Oct; 19(10):1083-90. PubMed ID: 8886553 [TBL] [Abstract][Full Text] [Related]
49. [123I-MIBG myocardial scintigraphical analysis in patients with and without autonomic disorder]. Hakusui S; Yasuda T; Yanagi T; Takahashi A; Hasegawa Y; Inoue M Rinsho Shinkeigaku; 1994 Apr; 34(4):402-4. PubMed ID: 8026141 [TBL] [Abstract][Full Text] [Related]
50. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. De Marco T; Dae M; Yuen-Green MS; Kumar S; Sudhir K; Keith F; Amidon TM; Rifkin C; Klinski C; Lau D J Am Coll Cardiol; 1995 Mar; 25(4):927-31. PubMed ID: 7884099 [TBL] [Abstract][Full Text] [Related]
51. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid]. Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529 [TBL] [Abstract][Full Text] [Related]
52. [Scintigraphic imaging of adrenergic structures of the heart with 123(I)-metaiodobenzylguanidine in cardiomyopathy]. Grötz J; Franitza R; Mödder G; Hossmann V Z Kardiol; 1988 May; 77(5):278-81. PubMed ID: 3407271 [TBL] [Abstract][Full Text] [Related]
53. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. Langer A; Freeman MR; Josse RG; Armstrong PW J Am Coll Cardiol; 1995 Mar; 25(3):610-8. PubMed ID: 7860904 [TBL] [Abstract][Full Text] [Related]
54. 123I-MIBG myocardial imaging in hypertensive patients: abnormality progresses with left ventricular hypertrophy. Mitani I; Sumita S; Takahashi N; Ochiai H; Ishii M Ann Nucl Med; 1996 Aug; 10(3):315-21. PubMed ID: 8883707 [TBL] [Abstract][Full Text] [Related]
55. Use of [123I]MIBG to assess cardiac adrenergic innervation: experience in hypertensive cardiopathy and left ventricular aneurysms. Giordano A; Calcagni ML; Rufini V; Colivicchi F; Melina D; Melina G; Pristipino C; Nori S; Trani C; Santarelli P Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):44-8. PubMed ID: 9002748 [TBL] [Abstract][Full Text] [Related]
56. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake. Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980 [TBL] [Abstract][Full Text] [Related]
57. Clinical use of metaiodobenzylguanidine imaging in cardiology. Merlet P; Piot O; Dubois-Randé JL; Loisance D; Castaigne A; Syrota A Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):29-39. PubMed ID: 9002746 [TBL] [Abstract][Full Text] [Related]